Elínborg Jónsdóttir

BBA//Fjeldco recently advised Styrkás hf. on its agreement to acquire all of the share capital of Icelandic asphalt producer and paving contractor Malbiksstöðin ehf., together with the company's land plots at Esjumelar.  Part of the consideration will be paid in newly issued shares in Styrkás.. m. The acquisition creates a fifth core business line for Styrkás, adding capacity to build and maintain transport infrastructure. It also comes as the group prepares to list on the Nasdaq Iceland Main Market, targeted for Q2 2027. Completion remains subject to customary conditions, including approval by the Icelandic Competition Authority. .

The BBA//Fjeldco team consisted of Halldór Karl Halldórsson, Stefán Björn Stefánsson, Austri Þorsteinsson, Brynjar Freyr Garðarsson, Elínborg Jónsdóttir, Karolina Maria Krawczuk, Stefnir Guðmundsson and Arnar Heimir Lárusson.

We wish to congratulate Styrkás on this milestone, and thank everyone involved for the cooperation on this successful acquisition.

BBA//Fjeldco has advised Alvogen Iceland ehf., a subsidiary of Aztiq, on the sale of all of its share capital in the Icelandic pharmaceutical wholesaler Alvogen ehf. (unrelated to the US-based Alvogen Pharma) to Orbital ehf.. Founded in 2014 through the acquisition of pharmaceutical company Portfarma, Alvogen has grown considerably to become a major supplier to Iceland's pharmacies and healthcare institutions. The business now imports around 100 pharmaceuticals and markets more than 200 health-related products and medical devices, spanning the import, marketing and distribution of generic medicines, over-the-counter drugs and prescription medications, alongside other health products supplied to Iceland's leading healthcare institutions and pharmacies. Orbital ehf. is backed by venture capital fund Horn V and Silfurberg ehf. The transaction remains subject to approval from the Icelandic Competition Authority.